• Monday, Jul 04, 2022
  • Last Update : 03:54 pm

Pfizer/BioNTech to seek emergency vaccine approval in US Friday

  • Published at 12:58 pm November 20th, 2020
Covid-19 Vaccine
File photo: An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer on November 17, 2020 AFP

The FDA did not say how long it would take to review the data on vaccine efficacy and safety

An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech's co-founder said.

This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic.

"Pfizer's partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA," health secretary Alex Azar told a press conference Thursday in Washington.

BioNTech co-founder Ugur Sahin earlier told AFP in a Zoom interview: "The documents will be finalized today and tomorrow and submitted to the FDA."

The FDA did not say how long it would take to review the data on vaccine efficacy and safety, the two main criteria.

The scientific head of the US operation to develop a vaccine, Moncef Slaoui said Monday that the green light would probably come in December -- a timeframe echoed by Sahin.

He told AFP there is a chance they could receive the green light from the US "this year," and even starting delivering the vaccine by December.

The BioNTech/Pfizer shot and another one being developed by US firm Moderna have taken the lead in the global chase for a vaccine, after large-scale trial data this month showed that their jabs were around 95% effective against Covid-19.

The twin breakthroughs have lifted hopes for an end to a pandemic that has infected more than 56 million people and caused over 1.3 million deaths worldwide since the virus first emerged in China late last year.

"We would expect to see Moderna filing soon also," Azar said at the press conference.

The US, the European Union and a slew of other nations have already placed orders for hundreds of millions of doses of the top vaccine candidates in development.

Health workers, carers and people considered at high risk for severe Covid-19 are set to be first in line for the jabs.

'This is really solid' 

Both vaccines are based relatively new technology that uses a synthetic version of a molecule called "messenger RNA" to hack into human cells, and effectively turn them into vaccine-making factories.

No vaccine based on this platform has ever been approved.

The speed at which the vaccines have been developed has raised alarm in some quarters.

Traditional virus vaccines use actual viruses that can take months or years to develop.

But top US infectious disease official Anthony Fauci sought to dispell those concerns during a rare briefing by the White House task force Thursday.

"The process of the speed did not compromise at all safety nor did it compromise scientific integrity. It was a reflection of the extraordinary scientific advances in these types of vaccines which allowed us to do things in months that actually took years before," Fauci said.

"It was actually an independent body of people who have no allegiance to anyone -- not to the administration, not to me, not to the companies -- that looked at the data and deemed it to be sound," he continued.

"So we need to put to rest any concept that this was rushed in an inappropriate way. This is really solid."

50
Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail